|
Match
|
Document |
Document Title |
|
|
US20120028936 |
ORAL CONTRACEPTION WITH TRIMEGESTONE
The invention relates to a method for contraception comprising the administration of trimegestone to a woman of child-bearing age on at least 21 successive days, beginning on day 1 of the menstrual...
|
|
|
US20120021041 |
TRANSDERMAL DELIVERY
Dosing regimen for transdermal delivery of hormones comprising a 28 day treatment cycle with a fixed treatment interval and a fixed rest interval.
|
|
|
US20110256211 |
Transdermal Delivery
Dosing regimen for transdermal delivery of hormones comprising a 28 day treatment cycle with a fixed treatment interval and a fixed rest interval.
|
|
|
US20110046095 |
STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM
The present invention relates to steroid hormone products, such as oral contraceptive products, including at least one steroid active ingredient mixed with an excipient and having improved...
|
|
|
US20110275601 |
VERY LOW-DOSED SOLID ORAL DOSAGE FORMS FOR HRT
The present invention relates to a very low-dosed dosage form for hormone replacement therapy (HRT). More particularly, the present invention concerns a solid oral dosage form comprising about 0.5...
|
|
|
US20110256210 |
Transdermal Delivery
Dosing regimen for transdermal delivery of hormones comprising a monthly treatment cycle with a fixed treatment interval and a variable rest interval.
|
|
|
US20110172197 |
Dosace Form For Hormonal Contraceptive
A dosage form for hormonal contraception containing a given number of hormone-containing daily units and a given number of hormone-free daily units for daily, oral administration, where the...
|
|
|
US20110288059 |
NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE THEREFOR
Provided are methods for ameliorating a symptom of a neuropsychiatric disorder in a subject. Also provided are methods for ameliorating at least one physical symptom or at least one psychological...
|
|
|
US20100298279 |
Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology
This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several...
|
|
|
US20110053900 |
PROGESTERONE ANTAGONISTS SUCH AS CDB-4124 IN THE TREATMENT OF BREAST CANCER
The subject matter of the instant invention is pertinent to the field of cancer treatment. In particular, the instant invention is relevant to the treatment and/or prevention of breast cancer in a...
|
|
|
US20110071122 |
System for use by compounding pharmacists cists to produce hormone replacement medicine customized for each customer
This invention provides a system for compounding a pharmaceutical product for hormone replacement therapy. The system has a set of concentrated reagent compositions, each containing one or more...
|
|
|
US20110251163 |
Transdermal Delivery
Dosing regimen for transdermal delivery of hormones comprising a variable treatment cycle and a variable rest interval.
|
|
|
US20110189293 |
THERAPEUTIC REGIMENS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS
A method for treating an immunoinflammatory disorder in a subject in need thereof, said method comprising administering to said subject a unit dosage form comprising dipyridamole coated onto acid...
|
|
|
US20110003748 |
Method of treatment and compositions of D-chiro inositol and phosphates thereof
The present invention relates to the use of D-chiroinositol or a phosphate thereof in combination with folate for the reduction or prevention of congenital deformations such as anorectal...
|
|
|
US20110245211 |
METHOD FOR CONTRACEPTION
The invention relates to a method of contraception, which method comprises administering to a woman in need thereof an emergency contraception during one or two days, followed by a prolonged low...
|
|
|
US20110124611 |
METHODS OF HORMONAL TREATMENT UTILIZING CONTRACEPTIVE REGIMENS WITH CONTINUOUS ESTROGEN ADMINISTRATION
The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The...
|
|
|
US20120028935 |
Therapeutic Gestagens for the Treatment of Premenstrual Dysphoric Disorder
A method of treating premenstrual dysphoric disorders comprising administering to a patient in need of such treatment daily from day 1 to day 24 3 mg of drospirenone and 0.02 mg of ethinylestradiol.
|
|
|
US20110124612 |
MULTI-PHASE CONTRACEPTIVE PREPARATION BASED ON A NATURAL ESTROGEN
The multiphase preparation having higher contraceptive safety and reduced side effects is based on a combination of a natural oestrogen with dienogest or drospirenon. The multiphase prepration is...
|
|
|
US20120058171 |
ZOO-TECHNICAL DRUG DELIVERY DEVICE
The present invention relates to a veterinary zoo-technical drug delivery system (device) for the simultaneous release of two or more active substances, which system releases the active substances...
|
|
|
US20110009318 |
Transdermal Compositions and Methods for Treatment of Fibromyalgia and Chronic Fatigue Syndrome
Compositions and methods for alleviating the symptoms associated with chronic fatigue syndrome and fibromyalgia syndrome are provided. The compositions are based on use of a transdermal gel...
|
|
|
US20110028439 |
Combination hormone replacement therapy (HRT) and melatonin to prevent and treat mammary cancer
A combination hormone and melatonin therapy is provided to reduce the risk of developing, or to reduce the severity of, breast cancer by administering at least one estrogen hormone and optionally...
|
|
|
US20110077226 |
Methods for Inhibiting the Development of Huntington's Disease
This invention relates to Huntington's disease and more specifically to methods for inhibiting the development of or treating Huntington's disease by administering estrogen, testosterone,...
|
|
|
US20110281830 |
NOVEL DERMACEUTICAL CREAM MADE USING SODIUM FUSIDATE AND STEROIDS
The invention discloses a dermaceutical cream containing steroids and an antibacterial agent in the form of Fusidic acid, which Fusidic acid is formed in situ from Sodium Fusidate as the starting...
|
|
|
US20100120707 |
Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same
A dosage comprising an antibiotic, an estrogen, and a progestagen is provided. The dosage can be oral, or administered in other methods, such as intravaginally with a tampon. The dosage can be used...
|
|
|
US20110151003 |
TRANSDERMAL SYSTEMS CONTAINING MULTILAYER ADHESIVE MATRICES TO MODIFY DRUG DELIVERY
A transdermal drug-containing dosage unit comprises: a backing layer substantially impervious to the drug to be delivered transdermally; a first polymeric adhesive matrix, in contact with the...
|
|
|
US20110097405 |
ESTRADIOL-CONTAINING DRUG DELIVERY SYSTEM
The present invention relates to drug delivery systems in the form of thin water-soluble films (wafers), which contain estradiol, or derivatives thereof, in low amounts. The wafers of the present...
|
|
|
US20100279989 |
ORAL CONTRACEPTION WITH TRIMEGESTONE
The invention relates to a method for contraception comprising the administration of trimegestone to a woman of child-bearing age on at least 21 successive days, beginning on day 1 of the menstrual...
|
|
|
US20090247493 |
Regimens for Treatment of Conditions Related to Estrogen Deficiency
The present invention relates to methods of stimulating estrogen production that can be used to treat peri-menopausal or estrogen deficiency conditions utilizing regimens involving administration...
|
|
|
US20100021529 |
STEP-DOWN ESTROGEN REGIMEN FOR WOMEN RECEIVING ESTROGEN THERAPY
The present invention relates to methods for continuous treatment of diseases, conditions and/or symptoms associated with deficient endogenous levels of estrogen in a woman already receiving a...
|
|
|
US20110281831 |
NOVEL DERMACEUTICAL CREAM MADE USING SODIUM FUSIDATE, ANTIFUNGALS AND STEROIDS
The invention discloses a dermaceutical cream containing antifungal agents, steroids and an antibacterial agent in the form of Fusidic acid, which Fusidic acid is formed in situ from Sodium...
|
|
|
US20120015917 |
Use of Estrogenic Compounds in Combination with Progestogenic Compounds in Hormone-Replacement Therapy
The present invention relates to a pharmaceutical kit comprising a plurality of oral dosage units which comprise a progestogen. The progestogen is levonorgestrel, norgestimate, norethisterone,...
|
|
|
US20120064166 |
FORMULATION COMPRISING DROSPIRENONE FOR SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION
The present invention relates to a composition comprising Drospirenone dispersed in a liquid or semi-solid lipophilic vehicle. The present invention further relates to the use of such compositions...
|
|
|
US20080021003 |
EXTENDED STEP-DOWN ESTROGEN REGIMEN
The present invention relates to methods for treating diseases, conditions or symptoms associated with deficient endogenous levels of estrogen comprising administration of a higher first dose of an...
|
|
|
US20110059928 |
GRADUATED ESTROGEN CONTRACEPTIVE
A multiphasic estrogenic/progestogenic contraceptive regimen that provides for the reduction or elimination of estrogen in the initial phase is disclosed. Also described is a contraceptive kit that...
|
|
|
US20100279988 |
TRANSDERMAL DELIVERY SYSTEM FOR HORMONES AND STEROIDS
A transdermal delivery system comprising a composition comprising a pharmacological agent and a penetration enhancer wherein the penetration enhancer comprises polyethylene glycol (PEG) of average...
|
|
|
US20060106004 |
Unique methods and formulations of bio-identical sex steroids for the treatment of pathophysiologic aberrations of menopause
Consistent relief of physical and psychological disturbances in menopause is achieved by the administration of estrogenic hormones, which are bio-identical to natural estradiol and estriol, in a...
|
|
|
US20120035144 |
MEDICINAL FUSIDIC ACID CREAM MADE USING SODIUM FUSIDATE AND INCORPORATING A BIOPOLYMER, A CORTICOSTEROID, AND AN ANTIFUNGAL AGENT, AND A PROCESS TO MAKE IT.
The present invention is directed to a medicinal composition for treating skin inflammations, fungal/bacterial skin infections and related wounds, and also other skin wounds including those caused...
|
|
|
US20070004690 |
Quadraphasis continuous graduated estrogen contraceptive
A quadraphasic estrogenic/progestogenic contraceptive regimen that provides for a low level of estrogen in the initial phase and in the fourth phase is disclosed. Also described is a contraceptive...
|
|
|
US20120046254 |
DISPERSION OF PHYTOSTEROLS
The invention relates to a method for the production of highly stable aqueous dispersions of phytosterols, phytostanols and derivatives thereof, which allows the use of a wide range of emulsifiers...
|
|
|
US20060069071 |
Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations
Dermatitis can be effectively treated with the combined administration of dehydroepiandrosterone (DHEA) and a glucocorticoid. Systemic, topical and prepackaged DHEA-glucocorticoid embodiments are...
|
|
|
US20070207945 |
Extended cycle multiphasic oral contraceptive method
A multiphasic method of contraception comprising the steps of sequentially administering to a female of child bearing age a Phase I composition containing a progestogen in an amount equivalent to...
|
|
|
US20100004214 |
SEQUENTIAL SPRM/ PROGESTIN TREATMENT
The methods provided herein comprise administering a selective progesterone receptor modulator (SPRM) during a first dosing period and at least one progestogen during a second dosing period. The...
|
|
|
US20060089337 |
Estrogen replacement regimen
The present invention provides an improved method to deliver estrogen to menopausal women comprising administering ultra-low dose estradiol alternating with standard-dose estradiol.
|
|
|
US20060154907 |
Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
The present invention combines the administration of estrogens with the administration of non-aromatizing androgens to treat hormonal deficiencies in women undergoing estrogen replacement therapy.
|
|
|
US20120014915 |
Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders
The present invention discloses administering steroid hormones to mammals to treat autoimmune related diseases, including post-partum auto immune diseases) and more particularly. Most preferably...
|
|
|
US20100190757 |
COMBINATION PREPARATION FOR ORAL CONTREACEPTION AND ORAL THERAPY OF DYSFUNCTIONAL UTERINE BLEEDING CONTAINING ESTRADIOL VALERATE AND DIENOGEST AND METHOD OF USING SAME
The multiphase combination preparation for oral therapy of dysfunctional uterine bleeding and for oral contraception contains a first phase consisting of 2 daily dosage units, each containing 3 mg...
|
|
|
US20100297032 |
TRANSDERMAL DELIVERY SYSTEM
A transdermal delivery system comprising a composition comprising a physiologically active agent and a penetration enhancer wherein the penetration enhancer comprises a combination of (i) an ester...
|
|
|
US20110195031 |
METHODS FOR THE USE OF PROGESTOGEN AS A GLUCOCORTICOID SENSITIZER
Provided are methods and kits for administering progestogen as a glucocorticoid sensitizer to restore corticosteroid sensitivity or reverse the glucocorticoid insensitivity or enhance...
|
|
|
US20110201579 |
Method of Improving the Overall Health of a Patient by Application of Pregnenolone
A method is described herein for improving the overall health of a patient by providing subcutaneous pellets containing pregnenolone to at least one part of the body of the patient. In another...
|
|
|
US20090061026 |
NUTRACEUTIC PREPARATION IN POWDER FORM CONTAINING FREE PLANT STEROLS
The present invention relates to a nutraceutical preparation containing, in the same unit dose, a dried powder comprising free plant sterols in the global quantity of 0.5 to 3.0 g. The preparation...
|